Medtronic receives FDA approval for InterStim X™ syst

Medtronic receives FDA approval for InterStim X™ system, the next generation of the most personalized sacral nerve stimulation therapy for bladder and bowel control

/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it received approval from the U.S. Food and Drug...

Related Keywords

United States , Ireland , California , Dublin , Michigan , Grand Rapids , Americans , Jannahh Thompson , Katie Genereux , Mira Sahney , Ryan Weispfenning , Linkedin , Society Of Women , Value In Health , United States Census Bureau Web , Current Medical Research , Leede Research , Drug Administration , Department Of Economic , United Nations , Pelvic Health , Population Division , Exchange Commission , California Medicaid Program , Medtronic , Our Mission , Urologic Consultants , Interstim Micro , Neuroscience Portfolio , Social Affairs , World Population Prospects , States Quick , Medical Research , National Association , California Medicaid , Manag Care , Medtronic Plc ,